{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T19:01:25Z","timestamp":1773687685603,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100003747","name":"Department of Health, State Government of Victoria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003747","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006065","name":"Department of Health, Government of Western Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001782","name":"University of Melbourne","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001782","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s40264-025-01615-9","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T06:07:18Z","timestamp":1759298838000},"page":"353-365","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Statistical Methods for Multi-jurisdictional Australian Vaccine Safety Investigations of Rare Adverse Events"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8717-908X","authenticated-orcid":false,"given":"Hannah J.","family":"Morgan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5890-4254","authenticated-orcid":false,"given":"Lauren","family":"Bloomfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7594-0361","authenticated-orcid":false,"given":"Hazel J.","family":"Clothier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9565-7846","authenticated-orcid":false,"given":"Sera","family":"Ngeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7317-6531","authenticated-orcid":false,"given":"Gemma","family":"Cadby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3655-7587","authenticated-orcid":false,"given":"Dale","family":"Carcione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8925-8811","authenticated-orcid":false,"given":"James H.","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4960-326X","authenticated-orcid":false,"given":"Gonzalo Sepulveda","family":"Kattan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9905-2035","authenticated-orcid":false,"given":"Jim P.","family":"Buttery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8890-4201","authenticated-orcid":false,"given":"Paul","family":"Effler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"key":"1615_CR1","unstructured":"World Health Organization. Immunization 2019. Available from: https:\/\/www.who.int\/news-room\/facts-in-pictures\/detail\/immunization. Accessed 15 July 2025."},{"key":"1615_CR2","volume-title":"Global manual on surveillance of adverse events following immunization. 2016 update","author":"World Health Organization","year":"2014","unstructured":"World Health Organization. Global manual on surveillance of adverse events following immunization. 2016 update. Geneva: World Health Organization; 2014."},{"issue":"4","key":"1615_CR3","doi-asserted-by":"publisher","first-page":"189","DOI":"10.5694\/mja2.51662","volume":"217","author":"AC Cheng","year":"2022","unstructured":"Cheng AC, Buttery JP. Vaccine safety: what systems are required to ensure public confidence in vaccines? Med J Aust. 2022;217(4):189\u201390. https:\/\/doi.org\/10.5694\/mja2.51662.","journal-title":"Med J Aust"},{"issue":"4","key":"1615_CR4","doi-asserted-by":"publisher","first-page":"294","DOI":"10.33321\/cdi.2011.35.28","volume":"35","author":"HJ Clothier","year":"2011","unstructured":"Clothier HJ, Crawford NW, Kempe A, Buttery JP. Surveillance of adverse events following immunisation: the model of SAEFVIC, Victoria. Commun Dis Intell Q Rep. 2011;35(4):294\u20138. https:\/\/doi.org\/10.33321\/cdi.2011.35.28.","journal-title":"Commun Dis Intell Q Rep"},{"issue":"5","key":"1615_CR5","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1467-842x.1999.tb01297.x","volume":"23","author":"CDJ Holman","year":"1999","unstructured":"Holman CDJ, Bass AJ, Rouse IL, Hobbs MST. Population-based linkage of health records in Western Australia: development of a health services research linked database. Aust N Z J Public Health. 1999;23(5):453\u20139. https:\/\/doi.org\/10.1111\/j.1467-842x.1999.tb01297.x.","journal-title":"Aust N Z J Public Health"},{"key":"1615_CR6","unstructured":"Australian Bureau of Statistics. 1160.0 ABS Confidentiality Series 2017. https:\/\/www.abs.gov.au\/ausstats\/abs@.nsf\/Latestproducts\/1160.0Main%20Features4Aug%202017. Accessed 6 Sept 2025."},{"issue":"40","key":"1615_CR7","doi-asserted-by":"publisher","first-page":"5968","DOI":"10.1016\/j.vaccine.2021.07.059","volume":"39","author":"A Phillips","year":"2021","unstructured":"Phillips A, Carlson S, Danchin M, Beard F, Macartney K. From program suspension to the pandemic: a qualitative examination of Australia\u2019s vaccine pharmacovigilance system over 10 years. Vaccine. 2021;39(40):5968\u201381. https:\/\/doi.org\/10.1016\/j.vaccine.2021.07.059.","journal-title":"Vaccine"},{"issue":"4","key":"1615_CR8","doi-asserted-by":"publisher","first-page":"195","DOI":"10.5694\/mja2.51619","volume":"217","author":"L Deng","year":"2022","unstructured":"Deng L, Glover C, Dymock M, Pillsbury A, Marsh JA, Quinn HE, et al. The short term safety of COVID-19 vaccines in Australia: AusVaxSafety active surveillance, February\u2013August 2021. Med J Aust. 2022;217(4):195\u2013202. https:\/\/doi.org\/10.5694\/mja2.51619.","journal-title":"Med J Aust"},{"key":"1615_CR9","doi-asserted-by":"publisher","first-page":"1053637","DOI":"10.3389\/fpubh.2022.1053637","volume":"10","author":"I Laemmle-Ruff","year":"2022","unstructured":"Laemmle-Ruff I, Lewis G, Clothier HJ, Dimaguila GL, Wolthuizen M, Buttery J, et al. Vaccine safety in Australia during the COVID-19 pandemic: lessons learned on the frontline. Front Public Health. 2022;10:1053637. https:\/\/doi.org\/10.3389\/fpubh.2022.1053637.","journal-title":"Front Public Health"},{"issue":"6","key":"1615_CR10","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s40264-017-0520-7","volume":"40","author":"HJ Clothier","year":"2017","unstructured":"Clothier HJ, Crawford NW, Russell M, Kelly H, Buttery JP. Evaluation of \u2018SAEFVIC\u2019, a pharmacovigilance surveillance scheme for the spontaneous reporting of adverse events following immunisation in Victoria, Australia. Drug Saf. 2017;40(6):483\u201395. https:\/\/doi.org\/10.1007\/s40264-017-0520-7.","journal-title":"Drug Saf"},{"issue":"1","key":"1615_CR11","doi-asserted-by":"publisher","DOI":"10.23889\/ijpds.v2i1.406","volume":"2","author":"HF Gidding","year":"2017","unstructured":"Gidding HF, McCallum L, Fathima P, Snelling TL, Liu B, de Klerk N, et al. Probabilistic linkage of national immunisation and state-based health records for a cohort of 1.9 million births to evaluate Australia\u2019s childhood immunisation program. Int J Popul Data Sci. 2017;2(1):406. https:\/\/doi.org\/10.23889\/ijpds.v2i1.406.","journal-title":"Int J Popul Data Sci"},{"key":"1615_CR12","unstructured":"Centre for Health Analytics. Vaccine Safety Health Link (VSHL) 2021. https:\/\/www.healthanalytics.org.au\/directory\/vshl\/. Accessed 15 July 2025."},{"key":"1615_CR13","unstructured":"Department of Health and Aged Care. Using the Australian Immunisation Register 2023. https:\/\/www.health.gov.au\/topics\/immunisation\/immunisation-information-for-health-professionals\/using-the-australian-immunisation-register. Accessed 15 July 2025."},{"issue":"1","key":"1615_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2010-000016","volume":"1","author":"PK Armstrong","year":"2011","unstructured":"Armstrong PK, Dowse GK, Effler PV, Carcione D, Blyth CC, Richmond PC, et al. Epidemiological study of severe febrile reactions in young children in Western Australia caused by a 2010 trivalent inactivated influenza vaccine. BMJ Open. 2011;1(1):e000016. https:\/\/doi.org\/10.1136\/bmjopen-2010-000016.","journal-title":"BMJ Open"},{"issue":"1","key":"1615_CR15","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12911-022-02093-0","volume":"23","author":"H Abbasizanjani","year":"2023","unstructured":"Abbasizanjani H, Torabi F, Bedston S, Bolton T, Davies G, Denaxas S, et al. Harmonising electronic health records for reproducible research: challenges, solutions and recommendations from a UK-wide COVID-19 research collaboration. BMC Med Inform Decis Mak. 2023;23(1):8. https:\/\/doi.org\/10.1186\/s12911-022-02093-0.","journal-title":"BMC Med Inform Decis Mak"},{"issue":"Suppl._1","key":"1615_CR16","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1542\/peds.2010-1722H","volume":"127","author":"J Baggs","year":"2011","unstructured":"Baggs J, Gee J, Lewis E, Fowler G, Benson P, Lieu T, et al. The vaccine safety datalink: a model for monitoring immunization safety. Pediatrics. 2011;127(Suppl._1):S45-53. https:\/\/doi.org\/10.1542\/peds.2010-1722H.","journal-title":"Pediatrics"},{"issue":"2","key":"1615_CR17","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.23889\/ijpds.v4i2.1139","volume":"4","author":"JH Boyd","year":"2019","unstructured":"Boyd JH, Randall SM, Brown AP, Maller M, Botes D, Gillies M, et al. Population data centre profiles: Centre for Data Linkage. Int J Popul Data Sci. 2019;4(2):1139. https:\/\/doi.org\/10.23889\/ijpds.v4i2.1139.","journal-title":"Int J Popul Data Sci."},{"issue":"9","key":"1615_CR18","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1016\/j.vaccine.2024.01.100","volume":"42","author":"K Faksova","year":"2024","unstructured":"Faksova K, Walsh D, Jiang Y, Griffin J, Phillips A, Gentile A, et al. COVID-19 vaccines and adverse events of special interest: a multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals. Vaccine. 2024;42(9):2200\u201311. https:\/\/doi.org\/10.1016\/j.vaccine.2024.01.100.","journal-title":"Vaccine"},{"issue":"50","key":"1615_CR19","doi-asserted-by":"publisher","first-page":"2400164","DOI":"10.2807\/1560-7917.es.2024.29.50.2400164","volume":"29","author":"HJ Clothier","year":"2024","unstructured":"Clothier HJ, Parker C, Mallard JH, Effler P, Bloomfield L, Carcione D, et al. Real world Nuvaxovid COVID-19 vaccine safety profile after 100,000 doses in Australia, 2022\u20132023. Euro Surveill. 2024;29(50):2400164. https:\/\/doi.org\/10.2807\/1560-7917.es.2024.29.50.2400164.","journal-title":"Euro Surveill"},{"issue":"10","key":"1615_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0186839","volume":"12","author":"S Mowlaboccus","year":"2017","unstructured":"Mowlaboccus S, Mullally CA, Richmond PC, Howden BP, Stevens K, Speers DJ, et al. Differences in the population structure of Neisseria meningitidis in two Australian states: Victoria and Western Australia. PLoS ONE. 2017;12(10):e0186839. https:\/\/doi.org\/10.1371\/journal.pone.0186839.","journal-title":"PLoS ONE"},{"key":"1615_CR21","unstructured":"Kohl KS, Bonhoeffer J, Braun MM, et al. The brighton collaboration: creating a global standard for case definitions (and guidelines) for adverse events following immunization. In: Henriksen K, Battles JB, Marks ES, Lewin DI, editors. Advances in Patient Safety: From Research to Implementation (Volume 2: Concepts and Methodology). Rockville (MD): Agency for Healthcare Research and Quality (US); 2005."},{"issue":"5","key":"1615_CR22","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1002\/ana.26218","volume":"90","author":"J Osowicki","year":"2021","unstructured":"Osowicki J, Morgan H, Harris A, Crawford NW, Buttery JP, Kiers L. Guillain-barr\u00e9 syndrome in an Australian state using both mRNA and adenovirus-vector SARS-CoV-2 vaccines. Ann Neurol. 2021;90(5):856\u20138. https:\/\/doi.org\/10.1002\/ana.26218.","journal-title":"Ann Neurol"},{"key":"1615_CR23","unstructured":"Department of Health. Victorian Admitted Episodes Dataset (VAED) manual 2023-2024. 2023. https:\/\/www.health.vic.gov.au\/publications\/victorian-admitted-episodes-dataset-vaed-manual-2023-2024. Accessed 15 July 2025."},{"key":"1615_CR24","unstructured":"Department of Health. Hospital morbidity data collection, data dictionary 2023. https:\/\/www.datalinkageservices.health.wa.gov.au\/wp-content\/uploads\/2023\/08\/Hospital-Morbidity-Data-Collection-Data-Dictionary-2023.pdf. Accessed 15 July 2025."},{"key":"1615_CR25","unstructured":"Weldeselassie Y, Whitaker H, Farrington P. SCCS: the self-controlled case series method. 2024. https:\/\/cran.r-project.org\/web\/packages\/SCCS\/SCCS.pdf. Accessed 15 July 2025."},{"key":"1615_CR26","unstructured":"R Core Team. R: a language and environment for statistical computing. 2024. https:\/\/www.R-project.org\/. Accessed 15 July 2025."},{"issue":"3","key":"1615_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v036.i03","volume":"36","author":"W Viechtbauer","year":"2010","unstructured":"Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2010;36(3):1\u201348. https:\/\/doi.org\/10.18637\/jss.v036.i03.","journal-title":"J Stat Softw"},{"key":"1615_CR28","unstructured":"Department of Health and Aged Care. COVID-19 vaccine rollout update: 22 December 2022 Canberra. https:\/\/www.health.gov.au\/resources\/publications\/covid-19-vaccine-rollout-update-22-december-2022?language=en. Accessed 15 July 2025."},{"key":"1615_CR29","unstructured":"Department of Health and Aged Care. COVID-19 vaccine weekly safety report: 26-08-2021 Canberra: Australian Government; 2021. https:\/\/www.tga.gov.au\/news\/covid-19-vaccine-safety-reports\/covid-19-vaccine-weekly-safety-report-26-08-2021. Accessed 15 July 2025."},{"key":"1615_CR30","unstructured":"Department of Health and Aged Care. COVID-19 vaccine weekly safety report: 28-04-2021 Canberra: Australian Government; 2021. https:\/\/www.tga.gov.au\/news\/covid-19-vaccine-safety-reports\/covid-19-vaccine-weekly-safety-report-28-04-2021. Accessed 15 Jul 2025."},{"key":"1615_CR31","unstructured":"Department of Health and Aged Care. COVID-19 vaccine rollout update: 08 December 2023 Canberra: Australian Government; 2023. https:\/\/www.health.gov.au\/sites\/default\/files\/2023-12\/covid-19-vaccine-rollout-update-8-december-2023.pdf. Accessed 15 July 2025."},{"issue":"2","key":"1615_CR32","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/j.1600-0404.2004.00272.x","volume":"110","author":"G Bogliun","year":"2004","unstructured":"Bogliun G, Beghi E. Incidence and clinical features of acute inflammatory polyradiculoneuropathy in Lombardy, Italy, 1996. Acta Neurol Scand. 2004;110(2):100\u20136. https:\/\/doi.org\/10.1111\/j.1600-0404.2004.00272.x.","journal-title":"Acta Neurol Scand"},{"issue":"2","key":"1615_CR33","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1159\/000324710","volume":"36","author":"JJ Sejvar","year":"2011","unstructured":"Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population incidence of Guillain\u2013Barr\u00e9 syndrome: a systematic review and meta-analysis. Neuroepidemiology. 2011;36(2):123\u201333. https:\/\/doi.org\/10.1159\/000324710.","journal-title":"Neuroepidemiology"},{"issue":"21","key":"1615_CR34","doi-asserted-by":"publisher","first-page":"e2094","DOI":"10.1212\/wnl.0000000000207847","volume":"101","author":"S Le Vu","year":"2023","unstructured":"Le Vu S, Bertrand M, Botton J, Jabagi M-J, Drouin J, Semenzato L, et al. Risk of Guillain\u2013Barr\u00e9 syndrome following COVID-19 vaccines. Neurology. 2023;101(21):e2094\u2013102. https:\/\/doi.org\/10.1212\/wnl.0000000000207847.","journal-title":"Neurology"},{"issue":"7","key":"1615_CR35","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/j.vaccine.2024.02.032","volume":"42","author":"S Xu","year":"2024","unstructured":"Xu S, Sy LS, Hong V, Farrington P, Glenn SC, Ryan DS, et al. Mortality risk after COVID-19 vaccination: a self-controlled case series study. Vaccine. 2024;42(7):1731\u20137. https:\/\/doi.org\/10.1016\/j.vaccine.2024.02.032.","journal-title":"Vaccine"},{"issue":"6","key":"1615_CR36","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1111\/joim.12159","volume":"275","author":"G Trifir\u00f2","year":"2014","unstructured":"Trifir\u00f2 G, Coloma PM, Rijnbeek PR, Romio S, Mosseveld B, Weibel D, et al. Combining multiple healthcare databases for postmarketing drug and vaccine safety surveillance: why and how? J Intern Med. 2014;275(6):551\u201361. https:\/\/doi.org\/10.1111\/joim.12159.","journal-title":"J Intern Med"},{"issue":"1","key":"1615_CR37","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12874-016-0225-0","volume":"16","author":"S Hawken","year":"2016","unstructured":"Hawken S, Potter BK, Little J, Benchimol EI, Mahmud S, Ducharme R, et al. The use of relative incidence ratios in self-controlled case series studies: an overview. BMC Med Res Methodol. 2016;16(1):126. https:\/\/doi.org\/10.1186\/s12874-016-0225-0.","journal-title":"BMC Med Res Methodol"},{"issue":"10","key":"1615_CR38","doi-asserted-by":"publisher","first-page":"574","DOI":"10.5694\/mja12.10534","volume":"197","author":"NW Crawford","year":"2012","unstructured":"Crawford NW, Cheng A, Andrews N, Charles PG, Clothier HJ, Day B, et al. Guillain-barr\u00e9 syndrome following pandemic (H1N1) 2009 influenza A immunisation in Victoria: a self-controlled case series. Med J Aust. 2012;197(10):574\u20138. https:\/\/doi.org\/10.5694\/mja12.10534.","journal-title":"Med J Aust"},{"issue":"52","key":"1615_CR39","doi-asserted-by":"publisher","first-page":"7579","DOI":"10.1016\/j.vaccine.2022.10.084","volume":"40","author":"J Osowicki","year":"2022","unstructured":"Osowicki J, Morgan HJ, Harris A, Clothier HJ, Buttery JP, Kiers L, et al. Guillain-barr\u00e9 syndrome temporally associated with COVID-19 vaccines in Victoria, Australia. Vaccine. 2022;40(52):7579\u201385. https:\/\/doi.org\/10.1016\/j.vaccine.2022.10.084.","journal-title":"Vaccine"},{"key":"1615_CR40","unstructured":"Department of Health and Aged Care. COVID-19 vaccine weekly safety report: 13-05-2021 Canberra: Australian Government; 2021. https:\/\/www.tga.gov.au\/news\/covid-19-vaccine-safety-reports\/covid-19-vaccine-weekly-safety-report-13-05-2021. Accessed 15 July 2025."}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-025-01615-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40264-025-01615-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-025-01615-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T10:00:27Z","timestamp":1771668027000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40264-025-01615-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["1615"],"URL":"https:\/\/doi.org\/10.1007\/s40264-025-01615-9","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]},"assertion":[{"value":"24 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Hannah J. Morgan, Lauren Bloomfield, Hazel J. Clothier, Sera Ngeh, Gemma Cadby, Dale Carcione, James H. Boyd, Gonzalo Sepulveda Kattan, Jim P. Buttery and Paul Effler have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest\/competing interests"}},{"value":"All work conducted in Vaccine Safety Health Link is overseen by The Royal Children\u2019s Hospital Melbourne Ethics Committee (HREC 79964). All vaccine safety work conducted using the Western Australia Vaccination Linked Data Repository is conducted with approval from the relevant Data Custodians for the purposes of public health surveillance.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The Vaccine Safety Health Link platform uses whole-of-population routinely collected and de-identified data. Therefore, a waiver of consent was sought and approved for the Vaccine Safety Health Link project in line with Australia\u2019s National Statement section 2.3.10.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All data used in this study are sensitive and are not available for distribution.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"The R code is available upon request.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"All authors have contributed to the development of this article. All authors have read and approved the final version, and take responsibility for its contents. Concept and design: all authors. Statistical analysis: HM, LB, GK, GC. Drafting of the manuscript: HM, LB. Critical revision of the manuscript for important intellectual content: all authors. Administrative, technical or material support: HM, LB. Supervision: JPB, JHB, HJC.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 contributions"}}]}}